>

>

Comparison of ribavirin and placebo in Cdc group Iii human immunodeficiency virus infection

Griggs, J.

The Lancet 338(8758): 6-9

1991

DOI: 10.1016/0140-6736(91)90003-8

Document Number: 318486

Document emailed within 0-6 h

Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94

El-Ghazzawi, E.; Drew, L.; Hamdy, L.; El-Sherbini, E.; Sadek, S.e.-D.; Saleh, E. 1995: Intravenous drug addicts: a high risk group for infection with human immunodeficiency virus, hepatitis viruses, cytomegalo virus and bacterial infections in Alexandria Egypt Journal of the Egyptian Public Health Association 70(1-2): 127-150

Crumpacker, C.; Heagy, W.; Bubley, G.; Monroe, J.E.; Finberg, R.; Hussey, S.; Schnipper, L.; Lucey, D.; Lee, T.H.; McLane, M.F. 1987: Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and enhanced lymphocyte proliferation Annals of Internal Medicine 107(5): 664-674

Lang, D.J.; Kovacs, A.A.; Zaia, J.A.; Doelkin, G.; Niland, J.C.; Aledort, L.; Azen, S.P.; Fletcher, M.A.; Gauderman, J.; Gjerset, G.J. 1989: Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group Journal of Acquired Immune Deficiency Syndromes 2(6): 540-549

Sharkey, S.J.; Sharkey, K.A.; Sutherland, L.R.; Church, D.L. 1992: Nutritional status and food intake in human immunodeficiency virus infection. GI/HIV Study Group Journal of Acquired Immune Deficiency Syndromes 5(11): 1091-1098

Anonymous 1988: 1988 agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus Morbidity and Mortality Weekly Report 37(S-4): 22

Lin, W.-C.; Lin, H.-H.; Lee, S.S.-J.; Sy, C.-L.; Wu, K.-S.; Chen, J.-K.; Tsai, H.-C.; Chen, Y.-S. 2016: Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country Journal of Microbiology Immunology and Infection 49(5): 729-736

Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729

Panlilio, A.L.; Shapiro, C.N.; Schable, C.A.; Mendelson, M.H.; Montecalvo, M.A.; Kunches, L.M.; Perry, S.W.; Edwards, J.R.; Srivastava, P.U.; Culver, D.H. 1995: Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group Journal of the American College of Surgeons 180(1): 16-24

Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51

Segat, L.; Crovella, S. 2012: HLA-G 14bp del/ins genetic variation: association with susceptibility to human immunodeficiency virus-1 vertical transmission but not with human immunodeficiency virus-1 infection through horizontal transmission Tissue Antigens 80(1): 12-13

Soriano, V.; Gutiérrez, M.; Tuset, C.; Martínez-Zapico, R.; Ortiz de Lejarazu, R.; Aguilera, A.; Codina, G.; González, A.; Ulloa, F.; Leal, M. 1993: A multicenter study of infection with human immunodeficiency virus type-2 (HIV-2) in Spain (1991). the Spanish Group for the Study of HIV-2 Medicina Clinica 100(14): 531-535

Evans, B.A.; Mccormack, S.M.; Bond, R.A.; Macrae, K.D.; Thorp, R.W. 1988: Human immunodeficiency virus infection, hepatitis B virus infection, and sexual behaviour of women attending a genitourinary medicine clinic British Medical Journal 296(6620): 473-475

Del Olmo, J.A.; Añón, C.; Llovet, F.; Serra, M.A.; Wassel, A.; Rodrigo, J.M. 1995: Comparative study of the prevalence of hepatitis B virus infection and human immunodeficiency virus type 1 infection in the prison population between 1985 and 1992 Gastroenterologia y Hepatologia 18(8): 405-409

Cathebras, P.; Vohito, J.A.; Tamalet, C.; Yete, M.L.; Lagarde, R.; Vohito, M.D.; Ramiara, J.P.; Mbolidi, C.D.; Nama, J.; Ngbali, J.; Siopathis, M.R. 1988: Tuberculose et infection par le virus de l'immunodéficience humaine en République Centrafricaine - Tuberculosis and infection by the human immunodeficiency virus in central African Republic Medecine Tropicale 48(4): 401-407

Dercole, C.; Cravello, L.; Sperandeo, D.; Bretelle, F.; Piechon, L.; Boubli, L.; Blanc, B. 1996: Infection par le virus de l'immunodéficience humaine chez la femme enceinte : aspects généraux - Human immunodeficiency virus infection during pregnancy : generalities la Presse Medicale (1983) 25(2): 77-80

Blanche, S.; Rouzioux, C.; Moscato, M.L.; Veber, F.; Mayaux, M.J.; Jacomet, C.; Tricoire, J.; Deville, A.; Vial, M.; Firtion, G. 1989: A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group New England Journal of Medicine 320(25): 1643-1648

Sachithanandham, J.; Kannangai, R.; Abraham, A.M.; Fletcher, G.J.; Abraham, O.C.; Daniel, D.; Pulimood, S.A. 2013: Human herpes virus-8 infections among subjects with human immunodeficiency virus infection and normal healthy individuals in India Intervirology 56(4): 253-257

Polo Rodríguez, R.; Amador Prous, Cón.; Deig Comerma, E.Deig.; Fumazd, C.R.; Galindo Puerto, M..José.; Koerting de Castro, A.; Merino Muñoz, D.; Miralles Álvarez, C.; Muñoz Gálligo, E.; Núñez Cuadros, E.; Ollé Rodríguez, C.; Pérez Elías, M..Jesús.; Valencia Ortega, E.; Gisbert Civera, I. 2014: Consensus statement on assistance to women with human immunodeficiency virus infection in the health care sector. National AIDS Plan (PNS) and AIDS Study Group (GeSIDA) Enfermedades Infecciosas y Microbiologia Clinica 32(2): 99.E1-99.E14

Seligmann, M.; Pinching, A.J.; Rosen, F.S.; Fahey, J.L.; Khaitov, R.M.; Klatzmann, D.; Koenig, S.; Luo, N.; Ngu, J.; Riethmüller, G. 1987: Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update Annals of Internal Medicine 107(2): 234-242